The manifestation of early-onset GC has been observed as a constituent of Li–Fraumeni syndrome, indicating the requirement of timely and recurring endoscopic screening among individuals with germline TP53 mutations, especially in those with a family history of GC [60]. The gene discussed is TP53; the disease is gastric cancer.